中山哪家医院治痔疮最好中山混合痔医院手术,中山看脱肛哪里好,中山肛肠科 高新 医院,中山市医院肛瘘,中山肛门肿胀治疗,中山痔疮长在什么位置,中山华都肛肠科医院好不好

WASHINGTON, March 25 (Xinhua) -- NASA's Stardust spacecraft depleted fuel and ceased operation on Thursday after a 12-year run, the U.S. space agency said Friday."This is the end of the spacecraft's operations, but really just the beginnings of what this spacecraft's accomplishments will give to planetary science," said Lindley Johnson, Stardust-NExT and Discovery program executive at NASA headquarters in Washington."The treasure-trove of science data and engineering information collected and returned by Stardust is invaluable for planning future deep space planetary missions."Artist's concept of Stardust spacecraft nearing EarthLaunched on Feb. 7, 1999, Stardust flew past the asteroid named Annefrank and traveled halfway to Jupiter to collect the particle samples from the comet Wild 2. The spacecraft returned to Earth's vicinity to drop off a sample return capsule eagerly awaited by comet scientists.NASA re-tasked the spacecraft as Stardust-NExT to perform a bonus mission and fly past comet Tempel 1, which was struck by the Deep Impact mission in 2005. The mission collected images and other scientific data to compare with images of that comet collected by the Deep Impact.The Stardust-NExT met all mission goals, and the spacecraft was extremely successful during both missions. From launch until final rocket engine burn, it travelled approximately 3.54 billion miles.After the mileage logged in space, the Stardust team knew the end was near for the spacecraft. With its fuel tank empty and final radio transmission concluded, the most traveled comet hunter will move from NASA's active mission roster to retired."This kind of feels like the end of one of those old western movies where you watch the hero ride his horse toward the distant setting sun -- and then the credits begin to roll," said Stardust-NExT project manager Tim Larson from NASA's Jet Propulsion Laboratory in Pasadena, California. "Only there's no setting sun in space."

WASHINGTON, March 24 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year. It is a disease caused by the varicella-zoster virus, which is a virus in the herpes family and the same virus that causes chickenpox.After an attack of chickenpox, the virus lies dormant in certain nerves in the body. For reasons that are not fully understood, the virus can reappear in the form of shingles, more commonly in people with weakened immune systems and with aging."The likelihood of shingles increases with age. The availability of Zostavax to a younger age group provides an additional opportunity to prevent this often painful and debilitating disease" said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement. ( Shingles is characterized by a rash of blisters, which generally develop in a band on one side of the body and can cause severe pain that may last for weeks, and in some people, for months or years after the episode.Approval was based on a multicenter study conducted in the United States and four other countries in approximately 22,000 people who were 50-59 years of age. Half received Zostavax and half received a placebo. Study participants were then monitored for at least one year to see if they developed shingles. Compared with placebo, Zostavax reduced the risk of developing shingles by approximately 70 percent.The most common side effects observed in the study were redness, pain and swelling at the site of injection, and headache, according to the FDA.Zostavax, manufactured by Merck & Co., was originally approved on May 26, 2006, for the prevention of shingles in individuals 60 years of age and older.

XI'AN, March 31 (Xinhua) -- Archeologists in the northwestern Shaanxi Province confirmed Thursday, after weeks of lab work, that the bones they found in a bronze cooking vessel from a 2,400-year-old tomb belonged to a male dog under a year old.Altogether 37 bones were found in the cooking vessel, which was unearthed in November 2010 from a tomb near the Xianyang International Airport in the suburbs of Xi'an, said Liu Daiyun, a researcher with the Shaanxi Provincial Archeological Institute."When we opened the 20-cm tall cooking vessel, we were shocked to find bones and soup inside," said Liu.The bones and soup had all turned greenish, similar in color to the bronze container, he said.Cooking vessels were a typical offering Chinese once presented to their deceased ancestors, said Liu.The custom became prevalent around the Warring States Period (475 - 221 BC), the time Liu and his colleagues believed this dog stew was offered.Hu Songmei, a researcher who did most of the lab work to identify the bones, said they found the bones were "strikingly similar" to four complete sets of canine skeletons preserved at the institute's lab.The newly found bones, however, were smaller, indicating the dog was just a pup, said Hu.Hu said further lab work was needed to tell the exact species of the canine. "Dogs were domesticated by humans at least 10,000 years ago, but the early dog species that evolved from wild wolves could be very different from today's pet dogs."Besides the dog bones, experts also found a wine-like liquid in another airtight kitchen ware from the same tomb. "Whoever the tomb owner was, he must have loved liquor and meat, so his sons wished he could still enjoy the feast in his grave."

CHENGDU, May 8 (Xinhua) -- As a brand-name herbal capsule for cardiovascular disease in China, Di'ao Xinxuekang only needs to wait for another 15 years before reaching the EU market."The Dutch medical supervisors have recognized it as a qualified drug, but we still lack the evidence of 15-year presence in the EU market," said Ji Jianxin, a research manager with the drug's developer Di'ao Group based in southwest China's Sichuan Province.Di'ao, one of the largest Traditional Chinese Medicine (TCM) manufacturers, has been quite depressed, as many other TCM enterprises in China, by a European Union directive on traditional herbal medicinal products fully implemented from the beginning of this month.The directive requires that all herbal medicinal products, must obtain a medical license from any EU member state before it can be allowed in the EU market.It introduced a so-called simplified registration procedure with a seven-year transition period for traditional herbal medicinal products to be licensed, including Chinese and Indian ones.However, not a single Chinese herbal medicinal product has been granted the license so far, mainly due to the prohibitive registration cost and lack of required evidence to prove the product had a 30-year history of safe use, including 15 years in the EU.With a history of more than 2,000 years, TCM did not enter into the EU market until mid-1990s, and it has been imported into the EU and sold to European customers as food supplements instead of drugs.Most Chinese producers and importers did not reserve the customs papers a decade ago, thus unable to prove the 15-year use of their products in European markets.While TCM's globalization won't be doomed by one single EU directive as TCM export value to EU only takes up 14 percent of the total in 2010, experts and industry insiders still have had serious concerns about its future."Most TCM even don't have standardized labels that can help consumers to find out its origin," said Xian Sheng, from the China Association of TCM Export Companies.

BEIJING, Feb. 15 (Xinhua) -- China's health authorities Tuesday vowed to improve their response to food safety incidents.The ministry would issue a protocol "as early as possible" on how to respond to and investigate food safety incidents, said Vice Health Minister Chen Xiaohong at a national meeting on food safety in Beijing.It would also provide better training for officials and professionals working in the field, Chen said.Last year, the ministry initiated investigations into several incidents such as milk powder that allegedly caused infant girls to grow breasts and illegal soup additives by restaurants.In the milk powder case, the investigation found no evidence that Synutra International's products had caused the problem. Media reports said the company was the victim of dirty tricks by a rival firm.In addition, the ministry blacklisted 48 substances illegally added to food and 22 misused food additives last year.The ministry would include projects related to food safety in state-sponsored health programs giving free medical services to the public in next five years, Health Minister Chen Zhu said at the same meeting.But Chen did not give details about what kind of projects they will be.Under the current six state health programs, the government provides free cataract surgery for the needy, free breast and cervical examinations for rural women, free hepatitis B vaccines, free folic acid pills for rural women, new cooking stoves in rural homes to prevent fluorine poisoning caused by coal stoves as well as modern toilets for rural residents.